252 related articles for article (PubMed ID: 33462615)
21. Challenging case of tumour-induced osteomalacia.
Kumar P; Jadhav DV; Ravat SH; Jain N
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
[TBL] [Abstract][Full Text] [Related]
22. Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.
Ungari C; Rocchi G; Rinna C; Agrillo A; Lattanzi A; Pagnoni M
J Craniofac Surg; 2004 May; 15(3):523-7. PubMed ID: 15111823
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
[TBL] [Abstract][Full Text] [Related]
24. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
25. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
26. Oncogenous osteomalacia: a new case secondary to a malignant tumor.
Rico H; Fernandez-Miranda E; Sanz J; Gomez-Castresana F; Escriba A; Hernandez ER; Krsnik I
Bone; 1986; 7(5):325-9. PubMed ID: 3024684
[TBL] [Abstract][Full Text] [Related]
27. Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23.
Bansal S; Khazim K; Suri R; Martin D; Werner S; Fanti P
Clin Nephrol; 2016 Jan; 85(1):57-62. PubMed ID: 26521888
[TBL] [Abstract][Full Text] [Related]
28. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.
Cai Q; Hodgson SF; Kao PC; Lennon VA; Klee GG; Zinsmiester AR; Kumar R
N Engl J Med; 1994 Jun; 330(23):1645-9. PubMed ID: 8177270
[No Abstract] [Full Text] [Related]
29. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
[TBL] [Abstract][Full Text] [Related]
30. Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia.
Higley M; Beckett B; Schmahmann S; Dacey E; Foss E
Skeletal Radiol; 2015 Dec; 44(12):1825-31. PubMed ID: 26341245
[TBL] [Abstract][Full Text] [Related]
31. [Tumoral hypophosphatemic osteomalacia].
Santamaría Sandi J; Elorza Olabegoya R; Beitia Martín JJ; Vázquez García JA
Med Clin (Barc); 1985 Jun; 85(5):191-3. PubMed ID: 2991677
[No Abstract] [Full Text] [Related]
32. [FGF23 tumor induced osteomalacia].
Gronskaia SA; Belaya ZE; Melnichenko GA
Probl Endokrinol (Mosk); 2022 Jul; 68(5):56-66. PubMed ID: 36337019
[TBL] [Abstract][Full Text] [Related]
33. Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Imanishi Y; Hashimoto J; Ando W; Kobayashi K; Ueda T; Nagata Y; Miyauchi A; Koyano HM; Kaji H; Saito T; Oba K; Komatsu Y; Morioka T; Mori K; Miki T; Inaba M
J Bone Miner Metab; 2012 Jan; 30(1):93-9. PubMed ID: 21739089
[TBL] [Abstract][Full Text] [Related]
34. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
35. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
Alonso G; Varsavsky M
Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
[TBL] [Abstract][Full Text] [Related]
36. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
[TBL] [Abstract][Full Text] [Related]
37. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
38. Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia.
Amaratunga EA; Ernst EB; Kamau J; Kotala R; Snyder R
Cureus; 2021 Jun; 13(6):e15507. PubMed ID: 34268038
[TBL] [Abstract][Full Text] [Related]
39. Tumor induced osteomalacia.
Filipová L; Lazúrová I
Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
[TBL] [Abstract][Full Text] [Related]
40. Osteomalacia: a case series of patients with atypical clinical orthopaedic presentations.
Fok AW; Ng TP
Hong Kong Med J; 2010 Dec; 16(6):476-9. PubMed ID: 21135425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]